Oncology Analytics provides the critical missing link for health plans by helping to manage the total cost of cancer care. By providing access to current, evidence-based, disease-specific analytics on all cancer types and treatment options, backed by board-certified oncology physicians and pharmacists, health plans are able to provide their members with the ability to achieve the best possible outcomes.
Join the conversation
superwingy官网
安卓软件-免费软件站-香蕉加速器官网正版-哔咔哔咔加速器官方网址

e-Prior Authorization
Read More

Oncology Insights™
Read More

SuperWingy免费节点
Read More
安卓软件-免费软件站-香蕉加速器官网正版-哔咔哔咔加速器官方网址

安卓软件-免费软件站-香蕉加速器官网正版-哔咔哔咔加速器官方网址
National healthcare investor Baird Capital joins existing investors Oak HC/FT, McKesson Ventures and The Blue Venture Fund Atlanta, GA, May 26, 2025 — Oncology Analytics, a leading data analytics and technology-enabled services company dedicated to helping health...

安卓软件-免费软件站-香蕉加速器官网正版-哔咔哔咔加速器官方网址
Former Dana-Farber Associate Chief Medical Officer to Lead Company’s Clinical Team and Innovation Strategy
安卓软件-免费软件站-香蕉加速器官网正版-哔咔哔咔加速器官方网址

JAVELIN Bladder 100 Phase III Results: Maintenance Avelumab + Best Supportive Case vs. BSC Alone After Platinum-Based First-Line Chemotherapy in Advanced Urothelial Carcinoma
The following article, written by Melissa Pozotrigo, Senior Clinical Oncology Pharmacist at Oncology Analytics, is the final of a four-part series on key trends and findings from the 2025 American Society of Clinical Oncology (ASCO) Virtual Scientific Program, held May 29-31, 2025.

#2 Leverage Real-World Data and Analytics
The following article is the fourth in a five-part series on The Top Five Ways for Health Plans to Manage Oncology Drug Costs While Improving Member Treatment Options.
Events

Utilization Management: Addressing Crucial Challenges for Health Plans
Date: October 20-21
Embassy Suites by Hilton
Fort Lauderdale, FL

Is Prior Authorization the Best Approach for Oncology?
Available On-demand
Watch >>